Polyinosinic-polycytidylic acid sodium salt CAS NO.24939-03-5

Hangzhou Meiya Pharmaceutical Co., Ltd. which was founded in March of 2006, is mainly engaged in nucleotide series products, and it is a listed enterprise on the National Equities Exchange and Quotations(Stock Code: 833650). The predecessor of the company was Hangzhou Meiya Biotechnology Co., Ltd, which was founded in 1998. Through the whole progress, the company is always focusing on the development and production of preparation process, as well as process improvement. In November of 2012, Hangzhou Meiya set a wholly-owned company as its sales center: Shanghai Nucleosides Bio-Technology Co., Ltd. In January of 2014, Hangzhou Meiya set another wholly-owned company as its production site: Meiya Haian Pharmaceutical Co., Ltd., with a total investment exceeding 120 million RMB. Meiya has the Drug Production License and nearly 10,000 square meters of workshop of which meets GMP requirements.
Hangzhou Meiya, Shanghai Nucleosides Bio-Technology, and Meiya Haian Pharmaceutical all have their own import and export rights. Meiya produces more than 50 varieties, including nucleoside, nucleotide monophosphate, nucleotide diphosphate, nucleotide triphosphate, cyclic nucleotide, polynucleotide, yeast nucleotide, enzyme preparation, etc. Meiya is one of the top nucleotide manufacturers in China.

This advanced pharmaceutical intermediate applies developed enzymatic process, and it is produced in the GMP workshop which is under the quality management system of both China GMP and FSSC 22000. In addition, the QC lab is equipped with advanced HPLC, thin layer scanner, ultraviolet spectrophotometer, atomic flame spectrophotometer, gas chromatograph, etc. to strictly guarantee the quality monitor and management of each production step, which is in order to ensure the safety, stability and effectiveness of the product.

Quality system:

Meiya has been always followed the China GMP quality management system to produce its APIs and advanced pharmaceutical intermediates. Besides, Meiya also keeps following the FSSC22000 management system to produce food additives. Meiya owns an experienced quality management team and advanced hardware equipments, which ensure the safety, stable and efficacy of its products.

Hardware equipments:

Meiya owns workshops and advanced QC lab that strictly meet the requirement of GMP, also it is equipped with advanced HPLC, thin layer scanner, ultraviolet spectrophotometer, atomic flame spectrophotometer, gas chromatograph, etc. to strictly guarantee the quality monitor and management of each production step.

Application of veterinary: mainly used in the prevention and treatment of poultry,livestock viral diseases.It can be uese with many drugs.When it compatibility with APS,levamisole or ribavirin,there are obvious synergies;Compatibility with some antibiotics,there have a synergistic or additive effect.When it is added in many varietise of flour,powder,etc,there has a significant role in improving the effcacy of existing product,but does not interfere with the detection of the original product;This product has no species specificity,and can be widely used on poultry,pigs,cattle and other animals.

As a vaccine adjuvant,when it is used with the vaccine simultaneously,can play to make up the  immune blank period,relieve stress reaction of vaccines,enhance the role of the immune effcects;drug residues can be avoided or reduced.As a broad-spectrum antiviral drugs,it can be used:Chicken:infectious bronchitis,infectious laryngotracheitis,Newcastle disease,influenza,bursal disease,chicken pox.Duck:duck plague,duck viral hepatitis.Pigs:Pigs unnamed high fever(PRRS variants),PCV,PRRS,porcine reproductive and respiratory syndrome,porcine viral diarrhea,atypical swine fever.